Our study is the first to describe expression of the chemokine CXCL16 and its receptor CXCR6 on both cancer cells and adjacent T cells in human cancer and demonstrate correlations between expression of CXCL16 and CXCR6 and tumor progression. Here, CXCR6 is linked to cancer.